ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
AstraZeneca
National Institutes of Health Clinical Center (CC)
AstraZeneca
Royal Marsden NHS Foundation Trust
University of Colorado, Denver
CureOne